organisation

EFCG’s strategy and work are managed by three Committees and one task force who report to and are directed by the EFCG Board

BOARD

PRESIDENT: STEFFEN DENZINGER-MERCK KGaA
VICE-PRESIDENT: GILDAS BARREYRE-SEQENS

GENERAL ASSEMBLY

PRESIDENT: STEFFEN DENZINGER – MERCK KGaA
VICE-PRESIDENT: GILDAS BARREYRE – SEQENS

PHARMACEUTICAL ACTIVITIES
COMMITTEE

CHAIR: MARTIN J. KLATT – BASF
VICE-CHAIR: DENIS ANGIOLETTI – CERBIOS PHARMA

FINE CHEMICALS AND AGROCHEMICALS
MANUFACTURERS IN EUROPE

CHAIR: CHRISTINE CHARTROUX – WEYLCHEM
VICE-CHAIR: CHRISTOPH SCHAFFRATH – SALTIGO

INNOVATION COMMITTEE

CHAIR: JÜRGEN ROOS – SIEGFRIED
VICE-CHAIR: GIORGIO BERTOLINI – OLON

CSS TASK FORCE

CHAIR: ERIC KATEMAN – ASPEN OSS B.V.

BOARD OF DIRECTORS

PRESIDENT
Dr. Steffen Denzinger
Director Business Development Actives & Formulation –
Merck Life Science KGaA

VICE-PRESIDENT
Dr. Gildas Barreyre
Energy and Public Affairs Director –
SEQENS

Ms. Ana Marti
General Counsel, IP & RA – Medichem S.A

Mr. Matteo Reggente
Director – Aschimfarma Federchimica

Mr. Marco Gil
Senior Vice-President sales and marketing – Hovione

Dr. Christine Chartroux
Head of Sales & New Business development – WeylChem
Chair of the FAME Committee

Ms. Mila Jové
General Manager – Afaquim

Dr. Martin Jochen Klatt
Vice-President – BASF SE

Ms. Céline Crusson-Rubio
Managing Director – SICOS

Mrs. Sinead Keogh
Director – BioPharmaChem Ireland

Dr. Gian Paolo Negrisoli
President and CEO – Flamma Group

Dr. Roberta Pizzocaro
President Olon Group

Dr. Jürgen Roos
Chief Scientific Officer – Siegfried Holding AG

Dr. Vincent Touraille
Head of Strategy – EuroAPI – Sanofi Chimie

Ms. Julia Rumsch
Head of Brussels Office – BPI-German Pharmaceutical Industry Association

MANAGER

Mrs. Maggie Saykali
Director, Specialty Chemicals – Cefic

Mrs. Marta Siddu
Manager, Specialty Chemicals – Cefic